跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
ALEREST
Approved
STANDARD
ALEREST
LifeSquare Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
244c1b08369d9e7b
Company
LifeSquare Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
244c1b08369d9e7b
Drug Approval Philippines Name
ALEREST
Product Name
ALEREST
Registration Number
DRP-5185-06
Brand Name
ALEREST
Generic Name
CETIRIZINE (as dihydrochloride)
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
LifeSquare Laboratories, Inc.
Distributor
Westpoint Pharma Inc
Issuance Date
29 March 2024
Expiry Date
03 March 2029
Pharmacologic Category
ANTIHISTAMINE
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
244c1b08369d9e7b
Type
Standard
Back to Philippines FDA Approvals
ALEREST - Philippines FDA Drug Approval Details